ACCOUNTS - Final Accounts preparation

Registered number: 14574660

SURGO HEALTH UK LIMITED

UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

SURGO HEALTH UK LIMITED

COMPANY INFORMATION

Directors	Mala Gopal Gaonkar
	Sema Khairi Sgaier


Registered number	14574660


Registered office	3rd Floor
	12 Gough Square
	London
	EC4A 3DW

SURGO HEALTH UK LIMITED

REGISTERED NUMBER: 14574660

BALANCE SHEET

AS AT 31 DECEMBER 2024

		2024		2023
Note		£		£


Current assets
Debtors: amounts falling due within one year	4	100		100
Cash at bank and in hand		208,573		238,259
		208,673		238,359
Creditors: amounts falling due within one year	5	(159,601)		(217,575)
Net current assets			49,072		20,784
Total assets less current liabilities			49,072		20,784

Net assets			49,072		20,784

Capital and reserves
Called up share capital	100	100
Profit and loss account	48,972	20,684
	49,072	20,784

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 29 September 2025.

Sema Khairi Sgaier

Director

The notes on pages 2 to 5 form part of these financial statements.

Page 1

SURGO HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

1.	General information

Surgo Health UK Limited is a private limited company, incorporated in the United Kingdom and registered in England and Wales. The Company's registered office address is 3rd Floor, 12 Gough Square, London, EC4A 3DW.

In the prior period the company was incorporated on 6 January 2023, and so the comparatives are for the period from 6 January 2023 to 31 December 2023.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

2.2

Turnover

Turnover represents fees receivable for administrative support services provided during the year. Turnover is recognised when the services have been provided and is measured at a mark-up on costs in line with the Administrative Service Agreement.

2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 2

SURGO HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment.

2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

2.8

Creditors

Short-term creditors are measured at the transaction price.

Page 3

SURGO HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.9

Financial instruments

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Page 4

SURGO HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

Employees

The average monthly number of employees, including directors, during the year was 7 (2023 - 6).

Debtors

					2024	2023
					£	£


Called up share capital not paid	100	100
	100	100

5.	Creditors: Amounts falling due within one year
		2024	2023
		£	£

Amounts owed to group undertakings	34,763	112,753
Corporation tax	6,635	5,121
Other taxation and social security	23,042	16,474
Other creditors	35,157	25,436
Accruals and deferred income	60,004	57,791
	159,601	217,575

6.	Related party transactions
	The company has adopted the exemption permitted by paragraph 33.1A of FRS 102 and has not disclosed transactions with other group members.

7.	Controlling party

Surgo Health UK Limited is a wholly owned subsidiary of Surgo Health P.B.C. a company based in the United States of America, whose registered address is 1209 Orange Street, Wilmington, Delaware 19801.

The Ultimate controlling party of the group by virtue of shareholding is S K Sgaier.

Page 5